Editors' Pick Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS. Kappos L, Radue E-W, Comi G, Montalban X, Butzkueven H, Wiendl H, Giovannoni G, Hartung H-P, Derfuss T, Naegelin Y, et al. Neurology. 2015 May 29. Epub 1969 Dec 31. PMID: 26024899. Abstract CommentRecommendBookmarkWatch